Patents by Inventor Jacob H. Rand

Jacob H. Rand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assays for diagnosis of thrombophilic disease
    Patent number: 7252959
    Abstract: The present invention provides methods for diagnosing and/or monitoring thrombophilic disease in a patient that can result from the antiphospholipid antibody syndrome (aPL syndrome). The methods of the invention are premised on the inhibition of binding of an anticoagulant protein, annexin, preferably annexin-V, to phospholipids by antiphospholipid (aPL) antibodies in a patient blood sample.
    Type: Grant
    Filed: January 3, 2005
    Date of Patent: August 7, 2007
    Assignee: Mount Sinai School of Medicine of the City University of New York
    Inventor: Jacob H. Rand
  • Assays for diagnosis of thrombophilic disease
    Publication number: 20010044123
    Abstract: The present invention provides methods for diagnosing and/or monitoring thrombophilic disease in a patient that can result from the antiphospholipid antibody syndrome (aPL syndrome). The methods of the invention are premised on the inhibition of binding of an anticoagulant protein, annexin, preferably annexin-V, to phospholipids by antiphospholipid (aPL) antibodies in a patient blood sample.
    Type: Application
    Filed: February 28, 2001
    Publication date: November 22, 2001
    Applicant: Mount Sinai School of Medicine of the City University of New York
    Inventor: Jacob H. Rand
  • Assays for diagnosis of thrombophilic disease
    Patent number: 6284475
    Abstract: The present invention provides methods for diagnosing and/or monitoring thrombophilic disease in a patient that can result from the antiphospholipid antibody syndrome (aPL syndrome). The methods of the invention are premised on the inhibition of binding of an anticoagulant protein, annexin, preferably annexin-V, to phospholipids by antiphospholipid (aPL) antibodies in a patient blood sample.
    Type: Grant
    Filed: July 10, 1998
    Date of Patent: September 4, 2001
    Assignee: Mount Sinai School of Medicine of the City of New York
    Inventor: Jacob H. Rand